Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now known as Zeposia. A preliminary settlement of the 7-1/2-year-old class action was …
Musk Rips Twitter Verdict, Claims Jury’s $4.20 ‘Joke’ Mocked Him
Elon Musk’s lawyer says the billionaire didn’t get a fair trial because a San Francisco jury slipped a “bizarre and highly questionable” joke into a
